Inventor · disambiguated record
Scott D. Larsen
Also filed as: LARSEN SCOTT · LARSEN SCOTT D
46 granted patents·14 pending applications·202 citations·filing 1989–2025
97Inventor score
Files withUPJOHN CO13UNIV MICHIGAN REGENTS12LAPIX THERAPEUTICS INC6COLCA GERARD R4METABOLIC SOLUTIONS DEV CO LLC4
Top patents by PatentIndex Score
60 records- 0189US12016836B2Compositions and methods for reducing immune intolerance and treating autoimmune disordersLAPIX THERAPEUTICS INC·Filed 2023·Granted Jun 25, 2024·2 cites·21 claims
- 0289US11648225B2Compositions and methods for reducing immune intolerance and treating autoimmune disordersLAPIX THERAPEUTICS INC·Filed 2022·Granted May 16, 2023·2 cites·9 claims
- 0387US8946424B2Deuterated amlexanoxUNIV MICHIGAN·Filed 2014·Granted Feb 3, 2015·7 cites·9 claims
- 0484US6410585B1Inhibitors of protein tyrosine phosphataseFiled 1999·Granted Jun 25, 2002·36 cites·10 claims
- 0581US11220479B2Glucosylceramide synthase inhibitors and therapeutic methods using the sameUNIV MICHIGAN REGENTS·Filed 2020·Granted Jan 11, 2022·1 cites·20 claims
- 0681US9562012B2PPAR-sparing compounds for the treatment of metabolic diseasesMETABOLIC SOLUTIONS DEV CO LLC·Filed 2014·Granted Feb 7, 2017·6 cites·23 claims
- 0781US5565468APyridino substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agentsUPJOHN CO·Filed 1994·Granted Oct 15, 1996·21 cites·13 claims
- 0880US12390434B2Compositions and methods for reducing immune intolerance and treating autoimmune disordersLAPIX THERAPEUTICS INC·Filed 2024·Granted Aug 19, 2025·0 cites·18 claims
- 0979US10851072B2Inhibitors of Rho/MRTF/SRF-mediated gene transcription and methods for use of the sameUNIV MICHIGAN REGENTS·Filed 2019·Granted Dec 1, 2020·3 cites·17 claims
- 1079US6852731B2Antiviral compoundsPFIZER·Filed 2003·Granted Feb 8, 2005·15 cites·64 claims
- 1179US2025345302A1Compositions and Methods For Reducing Immune Intolerance and Treating Autoimmune DisordersLAPIX THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1278US10202340B2Glucosylceramide synthase inhibitors and therapeutic methods using the sameUNIV MICHIGAN REGENTS·Filed 2016·Granted Feb 12, 2019·3 cites·11 claims
- 1375US9126959B2PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseasesMETABOLIC SOLUTIONS DEV CO LLC·Filed 2014·Granted Sep 8, 2015·2 cites·1 claims
- 1474US9598441B2Therapeutic compounds and methodsRISHI ARUN K·Filed 2012·Granted Mar 21, 2017·4 cites·24 claims
- 1574US8961959B2Glucosylceramide synthase inhibitors and therapeutic methods using the sameUNIV MICHIGAN·Filed 2012·Granted Feb 24, 2015·3 cites·7 claims
- 1674US8912335B2PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseasesCOLCA GERARD R·Filed 2010·Granted Dec 16, 2014·2 cites·1 claims
- 1773US9504688B2Methods and compositions for treating bacterial infectionUNIV MICHIGAN REGENTS·Filed 2013·Granted Nov 29, 2016·3 cites·13 claims
- 1873US6274580B1Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitusUPJOHN CO·Filed 2000·Granted Aug 14, 2001·4 cites·23 claims
- 1971US8937182B2Synthesis for thiazolidinedione compoundsZELLER JAMES R·Filed 2011·Granted Jan 20, 2015·3 cites·1 claims
- 2068US6458788B14-hydroxycinnoline-3-carboxyamides as antiviral agentsUPJOHN CO·Filed 2001·Granted Oct 1, 2002·4 cites·20 claims
- 2164US10662183B2Inhibitors of myocardin-related transcription factor and serum response factor (MRTF/SRF)-mediated gene transcription and methods for use of the sameUNIV MICHIGAN REGENTS·Filed 2015·Granted May 26, 2020·1 cites·12 claims
- 2264US10590142B2Deuterated amlexanoxUNIV MICHIGAN REGENTS·Filed 2018·Granted Mar 17, 2020·0 cites·11 claims
- 2364US9365581B2Deuterated amlexanoxUNIV MICHIGAN·Filed 2014·Granted Jun 14, 2016·0 cites·9 claims
- 2461US6624160B24-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agentsUPJOHN CO·Filed 2001·Granted Sep 23, 2003·1 cites·24 claims
- 2561US6329545B1Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitusFiled 1999·Granted Dec 11, 2001·14 cites·3 claims
- 2660US8501722B2Methods and compositions for treating bacterial infectionGINSBURG DAVID·Filed 2010·Granted Aug 6, 2013·1 cites·7 claims
- 2759US9944652B2Deuterated amlexanoxUNIV MICHIGAN REGENTS·Filed 2016·Granted Apr 17, 2018·0 cites·10 claims
- 2859US8946435B2Synthesis for thiazolidinedione compoundsMETABOLIC SOLUTIONS DEV CO LLC·Filed 2014·Granted Feb 3, 2015·0 cites·3 claims
- 2959US5994577AAminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitusFiled 1995·Granted Nov 30, 1999·21 cites·3 claims
- 3058US2024351977A1Compositions and Methods For Reducing Immune Intolerance and Treating Autoimmune DisordersLAPIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3156US2023212123A1Pyridine Inhibitors of Glucosylceramide Synthase and Therapeutic Methods Using the SameUNIV MICHIGAN REGENTS·Filed 2021·Application pending·0 cites
- 3254US2025177340A1Tartaric Acid Analogs and Uses ThereofLAPIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3353US9468632B2Methods and compositions for targeting cancer stem cellsUNIV MICHIGAN REGENTS·Filed 2013·Granted Oct 18, 2016·0 cites·14 claims
- 3453US5955617AAminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitusUPJOHN CO·Filed 1997·Granted Sep 21, 1999·7 cites·2 claims
- 3552US2004180910A1Heterocycle carboxamides as antiviral agentsFiled 2004·Application pending·0 cites
- 3651US8293776B2Compositions and methods for treating inflammatory conditions of the bowelTEITELBAUM DANIEL H·Filed 2009·Granted Oct 23, 2012·0 cites·10 claims
- 3751US5723476A4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitusUPJOHN CO·Filed 1996·Granted Mar 3, 1998·12 cites·8 claims
- 3851US2004142928A1Heterocycle carboxamides as antiviral agentsFiled 2003·Application pending·0 cites
- 3949US2014018542A1Novel synthesis for thiazolidinedione compoundsMETABOLIC SOLUTIONS DEV CO LLC·Filed 2013·Application pending·0 cites
- 4047US6184216B1Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitusUPJOHN CO·Filed 1999·Granted Feb 6, 2001·4 cites·10 claims
- 4147US6177453B1Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitusUPJOHN CO·Filed 1999·Granted Jan 23, 2001·4 cites·7 claims
- 4247US6166080AAminoquanidine carboxylates for the treatment of obesityPHARMACIA IND·Filed 1995·Granted Dec 26, 2000·6 cites·11 claims
- 4347US2002082448A1Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitusUPJOHN CO·Filed 2001·Application pending·0 cites
- 4446US8895748B2Synthesis for thiazolidinedione compoundsTANIS STEVEN P·Filed 2011·Granted Nov 25, 2014·0 cites·38 claims
- 4543US6861438B2Antiviral agentsPFIZER·Filed 2003·Granted Mar 1, 2005·0 cites·50 claims
- 4643US5523318APyrrolidino-substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agentsUPJOHN CO·Filed 1995·Granted Jun 4, 1996·2 cites·4 claims
- 4743US2012322728A1Ppar-sparing thiazolidinediones and combinations for the treatment of diabetes mellitus and other metabolic diseasesCOLCA GERARD R·Filed 2010·Application pending·0 cites
- 4842US2013211095A1Novel synthesis for thiazolidinedione compoundsPARKER TIMOTHY·Filed 2011·Application pending·0 cites
- 4941US6353023B1Inhibitors of protein tyrosine phosphataseUPJOHN CO·Filed 1998·Granted Mar 5, 2002·5 cites·26 claims
- 5040US10329283B2G protein-coupled receptor kinase inhibitors and methods for use of the sameUNIV MICHIGAN REGENTS·Filed 2016·Granted Jun 25, 2019·0 cites·20 claims
Showing the top 50 of 60 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →